PROGNOSTIC-SIGNIFICANCE OF EOSINOPHILS AND MAST-CELLS IN RECTAL-CANCER - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (PROTOCOL R-01)

被引：112

作者：

FISHER, ER

PAIK, SM

ROCKETTE, H

JONES, J

CAPLAN, R

FISHER, B

机构：

来源：

HUMAN PATHOLOGY | 1989年 / 20卷 / 02期

关键词：

D O I：

10.1016/0046-8177(89)90180-9

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

收藏

页码：159 / 163

页数：5

相关论文

共 12 条

[1] CUTLER SJ, 1958, J CHRON DIS, V8, P699
[2] EHRLICH P, 1916, COLLECTED PAPERS P E, P1
[3] POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01
FISHER, B
WOLMARK, N
ROCKETTE, H
REDMOND, C
DEUTSCH, M
WICKERHAM, DL
FISHER, ER
CAPLAN, R
JONES, J
LERNER, H
GORDON, P
FELDMAN, M
CRUZ, A
LEGAULTPOISSON, S
WEXLER, M
LAWRENCE, W
ROBIDOUX, A
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01): : 21 - 29
[4] TISSUE MAST-CELLS IN BREAST-CANCER
FISHER, ER
SASS, R
WATKINS, G
JOHAL, J
FISHER, B
[J]. BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (03) : 285 - 291
[5] FISHER ER, UNPUB
[6] CERVICAL-CARCINOMA AND EOSINOPHIL .1. EOSINOPHIL CHEMOTACTIC FACTOR DERIVED FROM INVASIVE CERVICAL-CARCINOMA WITH EOSINOPHIL INFILTRATION
INOUE, T
IWASAKI, K
CHIHARA, T
TORISU, M
[J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1981, 21 (03): : 320 - 331
[7] JASS JR, 1987, LANCET, V1, P1303
[8] MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
[9] PRETLOW TP, 1984, AM J PATHOL, V116, P207
[10] PRETLOW TP, 1983, CANCER RES, V43, P2997